NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

心臟資訊系統的中國市場 ∼2024年:整合型系統、獨立型系統、心臟PACS

Cardiology Information System Market by System (Standalone, Integrated System, Cardiology Information System, Cardiology PACS), Component (Software, Services, Hardware), & End User (L3A Hospital, L3B and L2 Hospital) - China Forecast to 2024

出版商 MarketsandMarkets 商品編碼 911462
出版日期 內容資訊 英文 62 Pages
訂單完成後即時交付
價格
心臟資訊系統的中國市場 ∼2024年:整合型系統、獨立型系統、心臟PACS Cardiology Information System Market by System (Standalone, Integrated System, Cardiology Information System, Cardiology PACS), Component (Software, Services, Hardware), & End User (L3A Hospital, L3B and L2 Hospital) - China Forecast to 2024
出版日期: 2019年06月27日內容資訊: 英文 62 Pages
簡介

中國的心臟資訊系統市場預測將從2019年的3500萬美元到2024年達5400萬美元,以8.9%的年複合成長率 (CAGR) 成長。該市場的成長,由於心血管疾病的發病率上升的醫療圖像模式的使用擴大,中國的醫院數增加,及HCIT開發的政府措施等促進。另一方面,整合、互通性的課題,提供該市場大的課題。

本報告提供中國的心臟資訊系統市場調查,市場概要,對市場成長的各種影響因素及市場機會分析,各技能系統、零組件、終端用戶趨勢與市場規模的變化與預測,競爭環境,主要企業簡介等資訊彙整。

第1章 簡介

第2章 調查手法

第3章 市場概要

  • 簡介
  • 促進因素
  • 機會
  • 課題

第4章 中國的心臟資訊系統市場:各系統

  • 整合型系統
  • 獨立型系統

第5章 中國的心臟資訊系統市場:各零件

  • 軟體
  • 服務
  • 硬體設備

第6章 終端用戶分析

  • 簡介
  • L3A醫院
  • L3B & L2醫院
  • 第1級醫院

第7章 競爭情形

  • 市場佔有率分析
  • 中國的各企業的心臟資訊技術市場佔有率分析:各醫院類型

第8章 中國的心臟資訊系統市場:企業簡介

  • PHILIPS HEALTHCARE
    • 企業概要
    • 中國的提供產品
    • 產業概要
    • SWOT分析
    • 策略
  • CREALIFE MEDICAL TECHNOLOGY
  • CENTRAL DATA NETWORKS
  • ESAOTE CHINA LTD.

第9章 市場參與企業的考察

第10章 附錄

目錄
Product Code: HIT 7196

"The China cardiology information system market is projected to register a CAGR of 8.9% during the forecast period."

The China cardiology information system market is projected to reach USD 54 million by 2024 from USD 35 million in 2019, at a CAGR of 8.9%. Growth in this market is driven by the increasing use of medical imaging modalities due to the rising incidence of cardiovascular disease, an increasing number of hospitals in China, and government initiatives for HCIT development. On the other hand, integration and interoperability issues pose a major challenge in this market.

"The integrated systems segment will witness the highest growth during the forecast period."

Based on system, the China cardiology information system market is segmented into integrated and standalone systems. The integrated systems segment is projected to grow at the highest CAGR during the forecast period. Their cost-effectiveness and potential for workflow efficiency have contributed to their adoption.

"The Software segment will register the highest growth in the China cardiology information system market during the forecast period."

Based on component, the China cardiology information system market is segmented into software, services, and hardware. The software segment is projected to witness the highest growth in the China cardiology information system market during the forecast period. The growing need to integrate CVIS with C-PACS, EMRs, and other cardiology modules are the major factors supporting the growth of this segment.

"L3B and L2 hospitals are estimated to register the highest CAGR during the forecast period."

In this report, the China cardiology information system market is segmented into L3A, L3B, and L2 hospitals. The L3B and L2 hospitals segment is projected to register the highest growth rate during the forecast period, mainly due to the increasing number of such hospitals in the country.

Breakdown of Profiles of Primary Participants:

  • By Company Type: Tier 1: 20%, Tier 2: 45%, and Tier 3: 35%
  • By Designation: C-level: 30%, Director-level: 20%, and Others: 50%

Key players in the China cardiology information system market include Philips Healthcare (Netherlands), CREALIFE Medical Technology (China), Central Data Network (Australia), Infinitt Healthcare (South Korea), and Esaote (Italy).

Research Coverage:

The report analyzes the China cardiology information system market by system, component, and end user. Apart from comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by market players over the last three years. In addition, the company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and a forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, changes in strategic approach, and levels of output to remain successful in the market.

Key Benefits of Buying the Report:

This report will enable both established firms and new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the China cardiology information system market
  • Product Development/Innovation: Detailed insights on the product approvals, R&D activities, and product launches in the China cardiology information system market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the China cardiology information system market
  • Market Diversification: Exhaustive information about new products, recent developments, and investments in the China cardiology information system market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 INTRODUCTION
  • 1.2 OBJECTIVES OF THE STUDY

2 RESEARCH METHODOLOGY

3 MARKET OVERVIEW

  • 3.1 INTRODUCTION
  • 3.2 DRIVERS
    • 3.2.1 RISING INCIDENCE AND PREVALENCE OF CARDIOVASCULAR DISEASE IN CHINA
    • 3.2.2 INCREASING NUMBER OF HOSPITALS IN CHINA
    • 3.2.3 FAVORABLE GOVERNMENT INITIATIVES
  • 3.3 OPPORTUNITIES
    • 3.3.1 USE OF CLOUD-BASED SOLUTIONS
  • 3.4 CHALLENGES
    • 3.4.1 INTEGRATION AND INTEROPERABILITY

4 CHINA CARDIOLOGY INFORMATION SYSTEM MARKET, BY SYSTEM

  • 4.1 INTEGRATED SYSTEMS
  • 4.2 STANDALONE SYSTEMS

5 CHINA CARDIOLOGY INFORMATION SYSTEM MARKET, BY COMPONENT

  • 5.1 SOFTWARE
  • 5.2 SERVICES
  • 5.3 HARDWARE

6 CHINA CARDIOLOGY INFORMATION SYSTEM MARKET, BY END USER ANALYSIS

  • 6.1 INTRODUCTION
  • 6.2 L3A HOSPITALS
  • 6.3 L3B & L2 HOSPITALS
  • 6.4 LEVEL 1 HOSPITALS

7 CHINA CARDIOLOGY INFORMATION SYSTEM MARKET, BY END USER ANALYSIS

  • 7.1 MARKET SHARE ANALYSIS, 2018
  • 7.2 CHINA: CARDIOLOGY INFORMATION TECHNOLOGY MARKET SHARE ANALYSIS FOR INDIVIDUAL PLAYERS, BY HOSPITAL TYPE (2018)

8 CHINA CARDIOLOGY INFORMATION SYSTEM MARKET, COMPANY PROFILES

  • 8.1 PHILIPS HEALTHCARE
    • 8.1.1 COMPANY OVERVIEW
    • 8.1.2 PRODUCTS OFFERED IN CHINA
    • 8.1.3 BUSINESS OVERVIEW
    • 8.1.4 SWOT ANALYSIS
    • 8.1.5 STRATEGY
  • 8.2 CREALIFE MEDICAL TECHNOLOGY
    • 8.2.1 COMPANY OVERVIEW
    • 8.2.2 PRODUCTS OFFERED IN CHINA
    • 8.2.3 SWOT ANALYSIS
    • 8.2.4 STRATEGY
  • 8.3 CENTRAL DATA NETWORKS
    • 8.3.1 COMPANY OVERVIEW
    • 8.3.2 PRODUCTS OFFERED IN CHINA
    • 8.3.3 SWOT ANALYSIS
    • 8.3.4 STRATEGY
  • 8.4 ESAOTE CHINA LTD.
    • 8.4.1 COMPANY OVERVIEW
    • 8.4.2 PRODUCTS OFFERED IN CHINA
  • 8.5 INFINITT HEALTHCARE CO., LTD.
    • 8.5.1 COMPANY OVERVIEW
    • 8.5.2 PRODUCTS OFFERED IN CHINA

9 KEY INSIGHTS FROM INDUSTRY PARTICIPANTS

10 APPENDIX

  • 10.1 DISCUSSION GUIDE
  • 10.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 10.3 RELATED REPORTS
  • 10.4 AUTHORS DETAILS

LIST OF TABLES

  • TABLE 1: CHINA: CARDIOLOGY INFORMATION TECHNOLOGY MARKET, BY SYSTEM, 2017-2024 (USD MILLION)
  • TABLE 2: CHINA: CARDIOLOGY INFORMATION TECHNOLOGY MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 3: NUMBER OF HOSPITALS IN CHINA, 2009-2024
  • TABLE 4: CHINA: CARDIOLOGY INFORMATION TECHNOLOGY MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 5: INCREASING NUMBER OF L3A HOSPITALS IN CHINA, 2009-2024
  • TABLE 6: INCREASING NUMBER OF L3B & L2 HOSPITALS IN CHINA, 2009-2024
  • TABLE 7: CHINA: AVERAGE SELLING PRICE OF CARDIOVASCULAR INFORMATION TECHNOLOGY, BY END USER (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: DATA TRIANGULATION METHODOLOGY
  • FIGURE 2: MORTLITY RATE DUE TO HEART DISEASE IN CHINA
  • FIGURE 3: NUMBER OF HOSPITALS IN CHINA (IN THOUSAND)
  • FIGURE 4: PRIVATE VS. PUBLIC HOSPITALS IN CHINA (IN THOUSAND)
  • FIGURE 5: HEALTHCARE EXPENDITURE IN CHINA (IN USD)
  • FIGURE 6: CHINA CARDIOLOGY INFORMATION TECHNOLOGY MARKET SHARE ANALYSIS BY KEY PLAYERS, 2018
  • FIGURE 7: CHINA CARDIOLOGY INFORMATION TECHNOLOGY MARKET SHARE ANALYSIS FOR INDIVIDUAL PLAYERS BY HOSPITAL TYPE, 2018
  • FIGURE 8: PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2018)